| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |